We are live on ! Find out more
CCXI icon

ChemoCentryx

Delisted

CCXI was delisted on the 19th of October, 2022.

89 hedge funds and large institutions have $173M invested in ChemoCentryx in 2016 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 17 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 4

135% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 17

98% more call options, than puts

Call options by funds: $103K | Put options by funds: $52K

38% more capital inflows, than outflows

Capital inflows: $21.5M | Capital outflows: $15.5M

24% more funds holding

Funds holding: 72 → 89 (+17)

1.56% more ownership

Funds ownership: 47.43% → 49% (+1.6%)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
89
Holders Change
+17
Holders Change %
+23.61%
% of All Funds
2.22%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
22
Increased
40
Reduced
17
Closed
4
Calls
$103K
Puts
$52K
Net Calls
+$51K
Net Calls Change
-$43K

CCXI Hedge Fund Activity: Q4 2016 in Review

89 of the 4,009 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx (CCXI) for Q4 2016, worth a combined $173M — up 27% from $137M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CCXI positions and 4 closed out — a net gain of 18 holders — while 40 added to existing stakes and 17 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $2.72M. The largest seller was Artal Group, cutting an estimated $4.71M.

  • 89 institutional investors held ChemoCentryx (CCXI) as of Q4 2016, up from 72 in Q3 2016.
  • Funds reported $173M of ChemoCentryx stock for Q4 2016, up 27% quarter-over-quarter.
  • 22 funds opened new ChemoCentryx positions in Q4 2016 and 4 closed out, a net change of +18 holders.
  • The largest ChemoCentryx buyer in Q4 2016 was AllianceBernstein, an estimated $2.72M added.
  • The largest ChemoCentryx seller in Q4 2016 was Artal Group, an estimated $4.71M sold.

Based on aggregated 13F filings for Q4 2016.